Terms: = Pancreatic cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
35 results:
1. Current role of Nuclear Medicine in the diagnosis and therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Georgakopoulos A
Hell J Nucl Med; 2023; 26 Suppl():49-51. PubMed ID: 37658564
[TBL] [Abstract] [Full Text] [Related]
2. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
[TBL] [Abstract] [Full Text] [Related]
3. What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
Stiefel R; Lehmann K; Winder T; Siebenhüner AR
BMC Cancer; 2023 Feb; 23(1):148. PubMed ID: 36782152
[TBL] [Abstract] [Full Text] [Related]
4. Resistance of neuroendocrine tumours to somatostatin analogs.
Angelousi A; Koumarianou A; Chatzellis E; Kaltsas G
Expert Rev Endocrinol Metab; 2023 Jan; 18(1):33-52. PubMed ID: 36651768
[TBL] [Abstract] [Full Text] [Related]
5. Saikosaponin-A Exhibits Antipancreatic cancer Activity by Targeting the EGFR/PI3K/Akt Pathway.
Shi C; Sun L; Fang R; Zheng S; Yu M; Li Q
Curr Pharm Biotechnol; 2023; 24(4):579-588. PubMed ID: 35692139
[TBL] [Abstract] [Full Text] [Related]
6. Real-world comparison of healthcare resource utilization and costs of [
Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
[TBL] [Abstract] [Full Text] [Related]
7. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort.
Lithgow K; Venkataraman H; Hughes S; Shah H; Kemp-Blake J; Vickrage S; Smith S; Humphries S; Elshafie M; Taniere P; Diaz-Cano S; Dasari BVM; Almond M; Ford S; Ayuk J; Shetty S; Shah T; Geh I
Sci Rep; 2021 Sep; 11(1):17947. PubMed ID: 34504148
[TBL] [Abstract] [Full Text] [Related]
8. Clinical and phenotypical characteristics of submucosal invasive carcinoma in non-ampullary duodenal cancer.
Matsueda K; Kanzaki H; Takenaka R; Nakagawa M; Matsueda K; Iwamuro M; Kawano S; Kawahara Y; Toji T; Tanaka T; Yagi T; Fujiwara T; Okada H
PLoS One; 2021; 16(8):e0256797. PubMed ID: 34449813
[TBL] [Abstract] [Full Text] [Related]
9. Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results-Medicare analysis of 5235 patients.
Ni K; Yang JY; Baeg K; Leiter AC; Mhango G; Gallagher EJ; Wisnivesky JP; Kim MK
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1387. PubMed ID: 33835729
[TBL] [Abstract] [Full Text] [Related]
10. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
[TBL] [Abstract] [Full Text] [Related]
11. Digoxin use is associated with pancreatic cancer risk but does not affect survival.
Boursi B; Huber JS; Haynes K; Mamtani R; Yang YX
Cancer Causes Control; 2021 Jan; 32(1):41-46. PubMed ID: 33064241
[TBL] [Abstract] [Full Text] [Related]
12. Nomograms predict survival outcomes for distant metastatic pancreatic neuroendocrine tumor: A population based STROBE compliant study.
Li G; Tian ML; Bing YT; Wang HY; Yuan CH; Xiu DR
Medicine (Baltimore); 2020 Mar; 99(13):e19593. PubMed ID: 32221079
[TBL] [Abstract] [Full Text] [Related]
13. Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.
Brighi N; Panzuto F; Modica R; Gelsomino F; Albertelli M; Pusceddu S; Massironi S; Lamberti G; Rinzivillo M; Faggiano A; Spallanzani A; Ferone D; Prinzi N; Rossi RE; Annibale B; Colao AM; Campana D
Oncologist; 2020 Mar; 25(3):259-265. PubMed ID: 32162819
[TBL] [Abstract] [Full Text] [Related]
14. Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center.
Jalbert JJ; Casciano R; Meng J; Brais LK; Pulgar SJ; Berthon A; Dinet J; Kulke MH
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31999024
[TBL] [Abstract] [Full Text] [Related]
15. MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY (MRCP) VERSUS ENDOSONOGRAPHY-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA) FOR diagnosis AND FOLLOW-UP OF pancreatic INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS.
Costa DAPD; Guerra JG; Goldman SM; Kemp R; Santos JS; Ardengh JC; Ribas CAPM; Nassif PAN; Ribas-Filho JM
Arq Bras Cir Dig; 2019; 32(4):e1471. PubMed ID: 31859924
[TBL] [Abstract] [Full Text] [Related]
16. Metformin Use and pancreatic cancer Survival among Non-Hispanic White and African American U.S. Veterans with Diabetes Mellitus.
Toriola AT; Luo S; Thomas TS; Drake BF; Chang SH; Sanfilippo KM; Carson KR
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):169-175. PubMed ID: 31685560
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of circulating blood and tissue biopsy PDX1 and MSX2 gene expression in patients with pancreatic cancer: A case-control experimental study.
Duarte-Medrano G; Lopez-Méndez I; Ramírez-Luna MÁ; Valdovinos-Andraca F; Cruz-Martínez R; Medina-Vera I; Pérez-Monter C; Téllez-Ávila FI
Medicine (Baltimore); 2019 Jun; 98(26):e15954. PubMed ID: 31261501
[TBL] [Abstract] [Full Text] [Related]
18. Cytohistological diagnosis of pancreatic serous cystadenoma: a multimodal approach.
Steel M; Rao S; Ho J; Donnellan F; Yang HM; Schaeffer DF
J Clin Pathol; 2019 Sep; 72(9):615-621. PubMed ID: 31235542
[TBL] [Abstract] [Full Text] [Related]
19. Gamma Emitters in pancreatic Endocrine Tumors Imaging in the PET Era: Is there a Clinical Space for 99mTc-peptides?
Briganti V; Cuccurullo V; Di Stasio GD; Mansi L
Curr Radiopharm; 2019; 12(2):156-170. PubMed ID: 30827276
[TBL] [Abstract] [Full Text] [Related]
20. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
[TBL] [Abstract] [Full Text] [Related]
[Next]
